Peking Union Medical College Hospital, also known as Beijing Xiehe Hospital, is a renowned general hospital in Beijing, China. It was founded in 1921 by Rockefeller Foundation and is affiliated to both Peking Union Medical College and Chinese Academy of Medical Sciences.

During the past decade, Peking Union Medical College Hospital conducted 62 clinical trials. In the 10-year time frame, 62 clinical trials started and 14 clinical trials were completed, i.e. on average, 22.6% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 13 clinical trials were completed. i.e. 41.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Peking Union Medical College Hospital" #1 sponsor was "Hoffmann-La Roche" with 25 trials, followed by "Peking Union Medical College Hospital" with 16 trials sponsored, "Merck Sharp & Dohme LLC" with 12 trials sponsored, "Eli Lilly and Company" with 5 trials sponsored and "Betta Pharmaceuticals Co., Ltd." with 5 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Peking Union Medical College Hospital" #1 collaborator was "Eisai Inc." with 6 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "Changhai Hospital" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Peking Union Medical College Hospital" are "Non-small Cell Lung Cancer" (4 trials), "Rheumatoid Arthritis" (4 trials), "Biliary Tract Carcinoma" (2 trials), "Carcinoma, Hepatocellular" (2 trials) and "Carcinoma, Non-Small-Cell Lung" (2 trials). Many other conditions were trialed in "Peking Union Medical College Hospital" in a lesser frequency.

Most popular intervention types in "Peking Union Medical College Hospital" are "Drug" (53 trials), "Biological" (14 trials), "Other" (5 trials), "Procedure" (5 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Pembrolizumab" (12 trials), "Atezolizumab" (9 trials), "Cisplatin" (9 trials) and "Carboplatin" (7 trials). Other intervention names were less common.

The vast majority of trials in "Peking Union Medical College Hospital" are 67 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Peking Union Medical College Hospital". undefined are not yet recruiting, 11 are recruiting, 20 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Peking Union Medical College Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Peking Union Medical College Hospital, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 46 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 3 trials that are defined as “Not Applicable".

Peking Union Medical College Hospital has several departments that took part in Clinical trials: "Department of ob gyn, Peking Union Medical College Hospital" - 20 trials, "Clinical Pharmacology Research Center Peking Union Medical College Hospital" - 3 trials, "Dept. Breast Surgery, PUMCH" - 2 trials, "Department of Anesthesiology, Peking Union Medical College Hospital" - 2 trials